EUVIMEDEUVIMED entdecken
Crossref

Effects of pomegranate exocarp extract on H. pylori-induced pancreatic EMT: Molecular mechanisms and therapeutic potential

Mariam A Abo-Saif, Ghada M Al-Ashmawy, Amany E Ragab, Lamiaa A Al-Madboly, Ahmed B M Mehany, Sherin R El-Afify

Cellular Signalling · 2024

DOI: 10.1016/j.cellsig.2024.111465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2024. Verfasst von Mariam A Abo-Saif und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt. Hauptthemen laut MEDLINE: Helicobacter pylori, Plant Extracts, Epithelial-Mesenchymal Transition, Pancreas. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Tanta University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Previous studies have linked Helicobacter pylori infection with pancreatic diseases, including cancer. PURPOSE: To explore the influence of pomegranate exocarp extract (PEE) on epithelial-mesenchymal transition (EMT) in H. pylori-induced pancreatic rat tissue and to uncover the underlying molecular mechanisms. STUDY DESIGN: Twenty-eight rats were divided into six groups: group 1 (negative control), group 2 (H. pylori-infected), group 3 (infected + PEE pretreatment), group 4 (infected + PEE treatment), group 5 (infected + metronidazole treatment), and group 6 (infected + metronidazole/PEE co-treatment). METHODS AND RESULTS: This study aimed to assess the effectiveness of pomegranate exocarp extract (PEE) in treating Helicobacter pylori infection and its associated pancreatic tissue changes in Wistar rats. The study involved Forty-eight male rats divided into six groups: H. pylori-infected control, PEE-preventive, PEE treatment, metronidazole treatment, PEE combined with metronidazole treatment, and negative control. The results showed a significant reduction in H. pylori concentration in the antrum in the PEE-treated groups (27.08 %) compared to that in the positive control group (p < 0.05). The group receiving the combined treatment exhibited the highest reduction (55.8 %) in H. pylori concentration (p < 0.005), with no significant difference observed between the PEE-preventive and metronidazole-treated groups. The ELISA results showed that the groups treated with PEE, PEE-preventive, and PEE combined with metronidazole experienced a significant increase in pancreatic E-cadherin levels by 47.7 %, 73.8 %, and 118.06 % respectively, and a substantial decrease in vimentin levels by 16.6 %, 31.6 %, and 43.5 % respectively, compared to the positive control group (p < 0.05). The results of the RT-qPCR analysis showed that the PEE treatment group, as well as the PEE preventive and PEE combined with metronidazole treatment groups, displayed significant downregulation of vimentin, sirtuin1, and lncRNA MALAT-1, and upregulation of E-cadherin compared to the positive control group. However, there was no significant difference between the PEE-preventive and metronidazole-treated groups (p < 0.05). Histopathological analysis showed considerable improvement in pancreatic tissue morphology in the PEE-treated groups. The inflammation score was significantly lower in these groups (p < 0.05), and the combined treatment group exhibited minimal signs of metaplasia and mononuclear cell infiltration. A computational study identified 54 human target genes of bioactive compounds in PEE. These findings shed light on the crucial interactions and pathways in treating pancreatic tumors. Additionally, GO enrichment and KEGG pathway analyses revealed significant pathways, such as the MAPK signaling and RTK pathway, enriched with genes targeted by PEE. Furthermore, evaluation of drug-likeness and ADME properties indicated that ellagic acid possesses drug-like properties and has a high potential for oral absorption. In conclusion, PEE has shown significant therapeutic potential in reducing H. pylori load and improving pancreatic tissue health while influencing key molecular markers and pathways associated with pancreatic tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriPlant ExtractsEpithelial-Mesenchymal TransitionPancreasHelicobacter InfectionsPomegranateRats, WistarAnimalsMaleRatsMetronidazole

Stichwörter der Autor:innen

EMTH. pyloriMALAT-1Pancreatic neoplasmPomegranate exocarp extractsirtuin1

Substanzen

Plant ExtractsMetronidazole

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt; Department of Biochemistry, Faculty of Pharmacy, AlSalam University, Kafr alzayat, Algharbia 31611, Egypt. Electronic address: Ghada…
  • Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
  • Zoology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, AlSalam University, Kafr alzayat, Algharbia 31,611, Egypt.

Förderung

  • Tanta University

Zitieren

APA

Abo-Saif, M. A., Al-Ashmawy, G. M., Ragab, A. E., Al-Madboly, L. A., Mehany, A. B. M., & El-Afify, S. R. (2024). Effects of pomegranate exocarp extract on H. pylori-induced pancreatic EMT: Molecular mechanisms and therapeutic potential. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111465

Vancouver

Abo-Saif MA, Al-Ashmawy GM, Ragab AE, Al-Madboly LA, Mehany ABM, El-Afify SR. Effects of pomegranate exocarp extract on H. pylori-induced pancreatic EMT: Molecular mechanisms and therapeutic potential. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111465

BibTeX
@article{AboSaif2024,
  author = {Abo-Saif, Mariam A and Al-Ashmawy, Ghada M and Ragab, Amany E and Al-Madboly, Lamiaa A and Mehany, Ahmed B M and El-Afify, Sherin R},
  title = {Effects of pomegranate exocarp extract on H. pylori-induced pancreatic EMT: Molecular mechanisms and therapeutic potential},
  journal = {Cellular Signalling},
  year = {2024},
  doi = {10.1016/j.cellsig.2024.111465}
}
Kostenlos starten →